Brevan Howard Capital Management’s Humana HUM Stock Holding History

Brevan Howard Capital Management’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.43M	Buy	+16,200	New	+$4.61M	0.05%	267

Other funds holding HUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brevan Howard Capital Management's HUM Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Humana (HUM) in Q2 2026, closing a stake of 8,335 shares — an estimated $2.37M sold.

Brevan Howard Capital Management first reported a position in HUM in Q3 2023 and held it in 4 quarters. The position peaked at $1.82M in Q2 2025. 925 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

Brevan Howard Capital Management reported no remaining Humana position as of Q2 2026 after selling out during the quarter.
Brevan Howard Capital Management sold 8,335 Humana shares in Q2 2026, an estimated $2.37M.
Brevan Howard Capital Management first reported a position in Humana in Q3 2023 and held it in 4 quarters.
Brevan Howard Capital Management's Humana position peaked at $1.82M in Q2 2025.
925 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.